The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement

Stefano Urso1, Filip Rega, Bart Meuris

  • 1Department of Cardiac Surgery, University Hospital Gasthuisberg, Leuven, Belgium. stefano_urso@inwind.it

Insights

The Contegra conduit, a bovine jugular vein graft, showed a higher incidence of graft replacement compared to homografts in right ventricle outflow tract reconstructions. Patients receiving the Contegra conduit were over twice as likely to need re-operation.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials in Medicine
  • Congenital Heart Disease Treatment

Background:

  • Valved conduits are essential for right ventricle outflow tract (RVOT) to pulmonary artery continuity in congenital heart diseases.
  • Graft replacement is a significant concern in RVOT reconstruction.

Purpose of the Study:

  • To compare graft replacement rates between the Contegra conduit (bovine jugular vein graft) and homografts in RVOT reconstructions.
  • Identify risk factors for graft replacement in RVOT conduits.

Main Methods:

  • Retrospective review of 347 RVOT conduits (Contegra: 54, Homografts: 293) implanted between 1989-2003.
  • Follow-up of 323 patients (median age 12.7 years) with 99.4% completeness (mean 5.9 years).
  • Analysis of indications including Tetralogy of Fallot, Ross operation, and others.

Main Results:

  • Freedom from graft replacement at 10 years was lower for Contegra (63.5%) versus homografts (81.4%) (p < 0.001).
  • Independent predictors for graft replacement included smaller graft size (≤ 20 mm), younger age (≤ 10.4 years), non-anatomical graft position, and use of the Contegra conduit.
  • Multivariable analysis confirmed Contegra conduit use as an independent risk factor (HR 3.7).

Conclusions:

  • The Contegra conduit is an independent risk factor for graft replacement in RVOT reconstructions.
  • Patients receiving Contegra conduits face a significantly higher likelihood of re-operation compared to those receiving homografts.
  • Graft size, patient age, and graft position also significantly influence the need for replacement.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...